Skip to main content

Peden Discusses Clinical Research Alliance in Triangle Business Journal Article

July 6, 2023
In a Triangle Business Journal article, David B. Peden, MD, discusses how UNC’s new Clinical Research Alliance (CRA) can be used to develop multi-site clinical trials. The article, “New UNC group wants to land larger clinical studies,” can be read here.

Peden Discuses Wildfire Pollution in NEWSTALK Tonight Podcast

June 21, 2023
David B. Peden, MD, was interviewed in a NEWSTALK Tonight radio broadcast on the topic of wildfire pollution. NEWSTALK Tonight is a feature on the NEWSTALK 1010 Internet radio channel out of Toronto, Canada. You can listen to a recording of the broadcast with Dr. Peden here.

Peden to Serve as Faculty Lead for Newly-Launched Clinical Research Alliance

June 21, 2023
The UNC School of Medicine has launched its Clinical Research Alliance (CRA), an organization within the school that will streamline all aspects of its clinical research enterprise, including ground-up support for scientists conducting multi-site trials, industry partners interested in collaboration leading toward new treatments and discoveries, as well as people...

Peden Consulted for Article on Air Quality Warnings & Safety

June 8, 2023
David Peden, MD, was consulted for a Raleigh News & Observer article on precautions that can be taken during air quality warnings. The article, “With air quality warnings in NC, what should I do or not do to stay safe? Experts answer,” can be found here.

Pickles et al Study Shows Key Role for Human T Cells in the Control of Respiratory Syncytial Virus (RSV) Infection

June 1, 2023
Researchers at the UNC School of Medicine’s International Center for the Advancement of Translational Science, Department of Microbiology and Immunology, and Institute for Global Health and Infectious Diseases have demonstrated the important role of human T cells in controlling RSV infection in the absence of an antibody response. Led by J....

Goralski Consulted for Several Articles on Trikafta Age Limit Expansion

May 5, 2023
Jennifer Goralski, MD, has been consulted for several news articles reporting the FDA’s expansion of age limits for Trikafta to treat younger children with cystic fibrosis. Dr. Goralski was a lead principal investigator in the clinical trial on which the FDA based its decision. The articles can be found at...

Conlon Among Spotlighted AMR Collaborators

May 5, 2023
The Institute for Global Health & Infectious Diseases (IGHID) has a new hub of collaborative work focused on combating antimicrobial resistance (AMR). Leveraging the Institute’s pan-university framework, the program brings together expertise in basic science, pharmacology, epidemiology, clinical research, and environmental studies from schools and departments all across UNC. Among...

Tilley & Schworer Win 2023 Innovation Pilot Award

April 21, 2023
Stephen Tilley, MD, and Stephen Schworer, MD, PhD, won a 2023 Innovation Pilot Award for their project, “Use of Digital Inhaler Technology to Improve Outcomes in Asthma: A Feasibility Project and Clinical Study.” Read more about this year’s award here, and read a description of Tilley & Schworer’s project here.

Freeman Paper Shows Omicron Relies More on Sugars for Infection

April 19, 2023
A new study led by Ronit Freeman, PhD, shows that the SARS-CoV-2 omicron variant relies on sugars to increase its infectivity. A UNC College of Arts & Sciences article about the paper, “Evolving candy crush: New paper shows omicron relies more on sugars for infection,” can be read here. The...

Goralski Study on Triple Therapy for Children with CF Profiled in Healio

April 6, 2023
The website Healio has profiled a study led by Jennifer Goralski, MD, on triple therapy in young children with cystic fibrosis. The study, published in The American Journal of Respiratory and Critical Care Medicine, is titled “Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2 Through 5 Years with...